A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia (Q45231524)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia |
scientific article published in March 2005 |
Statements
1 reference
A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia (English)
1 reference
Kenneth S Bauer
1 reference
Judith E Karp
1 reference
Tushar S Garimella
1 reference
Suhlan Wu
1 reference
Ming Tan
1 reference
Douglas D Ross
1 reference
1 March 2005
1 reference
1 reference
29
1 reference
3
1 reference
263-271
1 reference
Identifiers
1 reference
1 reference